<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07297761</doc-number>
<kind>B2</kind>
<date>20071120</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>188 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Heloderma horridum </s213>
<s220>
<s221>
AMIDATION 
</s221>
<s222>
(39)...(39) 
</s222>
<s223>amidated Ser (Serinamide)</s223>
</s220>
</s200>
<s400> 1 
His Ser Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>2 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Heloderma suspectum </s213>
<s220>
<s221>
AMIDATION 
</s221>
<s222>
(39)...(39) 
</s222>
<s223>amidated Ser (Serinamide)</s223>
</s220>
</s200>
<s400> 2 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>3 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 3 
Xaa Xaa Xaa Gly Thr Xaa Xaa Xaa Xaa Xaa Ser Lys Gln Xaa Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Xaa Xaa Xaa Xaa Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>4 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 4 
Xaa Xaa Xaa Gly Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
 1               5                  10                  15 
Xaa Ala Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30 
Xaa Xaa Xaa Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>5 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 5 
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
 1               5                  10                  15 
Xaa Ala Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30 
Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>6 </s210>
<s211>30 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 6 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly 
            20                  25                  30 
</s400>
<s200>
<s210>7 </s210>
<s211>30 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 7 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly 
            20                  25                  30 
</s400>
<s200>
<s210>8 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 8 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Ala Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>9 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 9 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>10 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 10 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>11 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 11 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>12 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 12 
Tyr Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>13 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 13 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Tyr 
        35 
</s400>
<s200>
<s210>14 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 14 
His Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>15 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 15 
His Gly Glu Gly Thr Xaa Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>16 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 16 
His Gly Glu Gly Thr Phe Ser Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>17 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 17 
His Gly Glu Gly Thr Phe Ser Thr Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>18 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 18 
His Gly Glu Gly Thr Phe Thr Thr Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>19 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 19 
His Gly Glu Gly Thr Phe Thr Ser Glu Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>20 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 20 
His Gly Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>21 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 21 
His Gly Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>22 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 22 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Xaa Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>23 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 23 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Xaa Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>24 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 24 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Xaa Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>25 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 25 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Val Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>26 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 26 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Val Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>27 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 27 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Xaa Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>28 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 28 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Xaa Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>29 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 29 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Asp Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>30 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 30 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>31 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 31 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>32 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 32 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>33 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 33 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>34 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 34 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>35 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 35 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>36 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 36 
is Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>37 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 37 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>38 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 38 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>39 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 39 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa Ser 
        35 
</s400>
<s200>
<s210>40 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 40 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>41 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 41 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>42 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 42 
His Ala Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>43 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 43 
His Gly Glu Gly Ala Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>44 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 44 
His Gly Glu Gly Thr Ala Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>45 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 45 
His Gly Glu Gly Thr Phe Thr Ala Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>46 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 46 
His Gly Glu Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>47 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 47 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ala Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>48 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 48 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Ala Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>49 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 49 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Ala Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>50 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 50 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ala Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>51 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 51 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Ala Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>52 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 52 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Ala 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>53 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 53 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Ala Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>54 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 54 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Ala Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>55 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 55 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Ala Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>56 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 56 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Ala Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>57 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 57 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Ala Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>58 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 58 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Ala Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>59 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 59 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Ala Lys Asn 
            20                  25 
</s400>
<s200>
<s210>60 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 60 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Ala Asn 
            20                  25 
</s400>
<s200>
<s210>61 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 61 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Ala 
            20                  25 
</s400>
<s200>
<s210>62 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 62 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro 
        35 
</s400>
<s200>
<s210>63 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 63 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro 
        35 
</s400>
<s200>
<s210>64 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 64 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro 
        35 
</s400>
<s200>
<s210>65 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 65 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro 
        35 
</s400>
<s200>
<s210>66 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 66 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro 
        35 
</s400>
<s200>
<s210>67 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 67 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro 
        35 
</s400>
<s200>
<s210>68 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 68 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala 
        35 
</s400>
<s200>
<s210>69 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 69 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala 
        35 
</s400>
<s200>
<s210>70 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 70 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly 
</s400>
<s200>
<s210>71 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 71 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly 
</s400>
<s200>
<s210>72 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 72 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser 
</s400>
<s200>
<s210>73 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 73 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser 
</s400>
<s200>
<s210>74 </s210>
<s211>32 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 74 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
</s400>
<s200>
<s210>75 </s210>
<s211>32 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 75 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
</s400>
<s200>
<s210>76 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 76 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro 
            20                  25                  30 
</s400>
<s200>
<s210>77 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 77 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro 
            20                  25                  30 
</s400>
<s200>
<s210>78 </s210>
<s211>30 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 78 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly 
            20                  25                  30 
</s400>
<s200>
<s210>79 </s210>
<s211>29 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 79 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly 
            20                  25 
</s400>
<s200>
<s210>80 </s210>
<s211>29 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 80 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly 
            20                  25 
</s400>
<s200>
<s210>81 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 81 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>82 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 82 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>83 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 83 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro 
        35 
</s400>
<s200>
<s210>84 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 84 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa 
        35 
</s400>
<s200>
<s210>85 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 85 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa 
        35 
</s400>
<s200>
<s210>86 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 86 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa 
        35 
</s400>
<s200>
<s210>87 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 87 
Arg Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala 
        35 
</s400>
<s200>
<s210>88 </s210>
<s211>30 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 88 
His Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly 
            20                  25                  30 
</s400>
<s200>
<s210>89 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 89 
His Gly Glu Gly Thr Xaa Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>90 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 90 
His Gly Glu Gly Thr Phe Ser Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>91 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 91 
His Gly Glu Gly Thr Phe Ser Thr Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>92 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 92 
His Gly Glu Gly Thr Phe Thr Ser Glu Leu Ser Lys Gln Met Ala Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>93 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 93 
His Gly Glu Gly Thr Phe Thr Ser Asp Xaa Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>94 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 94 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Xaa Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>95 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 95 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Xaa Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>96 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 96 
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Asp Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>97 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 97 
His Gly Glu Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser 
</s400>
<s200>
<s210>98 </s210>
<s211>29 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 98 
His Gly Glu Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly 
            20                  25 
</s400>
<s200>
<s210>99 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 99 
His Gly Glu Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa 
        35 
</s400>
<s200>
<s210>100 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 100 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>101 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 101 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>102 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 102 
His Gly Glu Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>103 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 103 
His Gly Glu Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>104 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s221>
AMIDATION 
</s221>
<s222>
(28)...(28) 
</s222>
<s223>amidated Asn (Asparaginamide)</s223>
</s220>
</s200>
<s400> 104 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>105 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 105 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>106 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 106 
His Gly Glu Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>107 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 107 
His Gly Glu Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>108 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 108 
His Gly Glu Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>109 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 109 
Ala Ala Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>110 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 110 
Ala Ala Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>111 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 111 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>112 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 112 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>113 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 113 
Ala Gly Asp Gly Ala Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>114 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 114 
Ala Gly Asp Gly Ala Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>115 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 115 
Ala Gly Asp Gly Thr Xaa Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>116 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Xaa in position 6 stands for naphthylalanine.</s223>
</s220>
</s200>
<s400> 116 
Ala Gly Asp Gly Thr Xaa Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>117 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 117 
Ala Gly Asp Gly Thr Phe Ser Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>118 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 118 
Ala Gly Asp Gly Thr Phe Ser Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>119 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 119 
Ala Gly Asp Gly Thr Phe Thr Ala Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>120 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 120 
Ala Gly Asp Gly Thr Phe Thr Ala Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>121 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 121 
Ala Gly Asp Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>122 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 122 
Ala Gly Asp Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>123 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 123 
Ala Gly Asp Gly Thr Phe Thr Ser Glu Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>124 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 124 
Ala Gly Asp Gly Thr Phe Thr Ser Glu Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>125 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 125 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>126 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 126 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>127 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 127 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Xaa Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>128 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 128 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Xaa Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>129 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 129 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ala Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>130 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 130 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ala Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>131 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 131 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Ala Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>132 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 132 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Ala Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>133 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 133 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Ala Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>134 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 134 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Ala Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>135 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 135 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ala Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>136 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 136 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Ala Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>137 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 137 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Xaa Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>138 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 138 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Xaa Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>139 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 139 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Ala Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>140 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 140 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Ala Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>141 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 141 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Ala 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>142 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 142 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Ala 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>143 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 143 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Ala Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>144 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 144 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Ala Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>145 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 145 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Ala Arg Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>146 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 146 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Ala Arg Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>147 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 147 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Ala Leu Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>148 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 148 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Ala Leu Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>149 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 149 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Ala Phe Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>150 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 150 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Ala Phe Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>151 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 151 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Xaa Ile Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>152 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 152 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Xaa Ile Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>153 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 153 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Val Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>154 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 154 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Val Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>155 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 155 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Xaa Glu Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>156 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 156 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Xaa Glu Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>157 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 157 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Asp Trp Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>158 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 158 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Asp Phe Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>159 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 159 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Ala Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>160 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 160 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Ala Leu Lys Asn 
            20                  25 
</s400>
<s200>
<s210>161 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 161 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Ala Lys Asn 
            20                  25 
</s400>
<s200>
<s210>162 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 162 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Ala Lys Asn 
            20                  25 
</s400>
<s200>
<s210>163 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 163 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Ala Asn 
            20                  25 
</s400>
<s200>
<s210>164 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 164 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Ala Asn 
            20                  25 
</s400>
<s200>
<s210>165 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 165 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Ala 
            20                  25 
</s400>
<s200>
<s210>166 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 166 
Ala Gly Asp Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Ala 
            20                  25 
</s400>
<s200>
<s210>167 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 167 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro 
        35 
</s400>
<s200>
<s210>168 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 168 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro 
        35 
</s400>
<s200>
<s210>169 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 169 
His Gly Glu Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro 
        35 
</s400>
<s200>
<s210>170 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 170 
His Gly Glu Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro 
        35 
</s400>
<s200>
<s210>171 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 171 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Ala Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro 
        35 
</s400>
<s200>
<s210>172 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 172 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala 
        35 
</s400>
<s200>
<s210>173 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 173 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala 
        35 
</s400>
<s200>
<s210>174 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 174 
His Gly Glu Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly 
</s400>
<s200>
<s210>175 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 175 
His Gly Glu Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser 
</s400>
<s200>
<s210>176 </s210>
<s211>32 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 176 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
</s400>
<s200>
<s210>177 </s210>
<s211>32 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 177 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
</s400>
<s200>
<s210>178 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 178 
His Gly Glu Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro 
            20                  25                  30 
</s400>
<s200>
<s210>179 </s210>
<s211>30 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 179 
His Gly Glu Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly 
            20                  25                  30 
</s400>
<s200>
<s210>180 </s210>
<s211>29 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 180 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly 
            20                  25 
</s400>
<s200>
<s210>181 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 181 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>182 </s210>
<s211>38 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 182 
His Gly Glu Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa Xaa 
        35 
</s400>
<s200>
<s210>183 </s210>
<s211>37 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 183 
His Gly Glu Gly Thr Phe Thr Ser Ala Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa Xaa 
        35 
</s400>
<s200>
<s210>184 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 184 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Xaa Ser 
            20                  25                  30 
Ser Gly Ala Xaa 
        35 
</s400>
<s200>
<s210>185 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 185 
His Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala 
        35 
</s400>
<s200>
<s210>186 </s210>
<s211>30 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 186 
His Gly Asp Ala Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly 
            20                  25                  30 
</s400>
<s200>
<s210>187 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 187 
Ala Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35 
</s400>
<s200>
<s210>188 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>artificially synthesized sequence of novel 
      exendin agonist compound</s223>
</s220>
</s200>
<s400> 188 
Ala Gly Ala Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Leu Glu Glu 
 1               5                  10                  15 
Glu Ala Val Arg Leu Phe Ile Glu Phe Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30 
Ser Gly Ala Pro Pro Pro Ser 
        35
</s400>
</sequence-list-new-rules>
</sequence-cwu>
